Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
The HELIOS B trial, recently published in NEJM, has unveiled promising results for patients with ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran, a cutting-edge siRNA therapy, significantly reduced the risk of death and cardiac events compared to placebo. Over 36 months, Vutrisiran also showed improvements in walking distance and quality of life. These findings highlight a […]
ISA 2024 Report
Click here to view a synopsis of the BU Amyloidosis Center’s attendance at the International Symposium on Amyloidosis at the Mayo Clinic May 26-30, 2024.
Statement on Amyloidosis by Ann Peel for the U.S. Senate
Click here to see full statement.
2024 Webinar: ATTR Cardiac Amyloidosis
What’s new and exciting in ATTR cardiac amyloidosis in 2024 Dr. Fredrick Ruberg and Dr. Omar Siddiqi discuss the general overview of ATTR treatment with new developments over the past year (APOLLO-B, ATTRibute-CM), currently enrolled trials (HELIOS-B, CARDIOTTRansform), and future trials (DepleTTR-CM, MAGNITUDE). They will also cover current heart failure therapy updates (SGLT2i) and imaging […]
Amyloidosis Language Included in the Fiscal Year 2024 Senate Bill and Report
2024 Omnibus Amyloidosis Report Language
17th Annual Bill’s Race to Beat Amyloid at Cannon
Our anonymous matching grant donor has raised the challenge to $7500 for 2024! Race & Silent Auction – Saturday, March 9th at 11 a.m. 17th Annual Bill’s Race to Beat Amyloid at Cannon March 1, 2023 – March 31, 2023 Register to race & be eligible to buy an all-mountain ticket for $55 Complete the […]
AL amyloidosis special session highlights: therapeutic advances and ongoing trials in the field
https://www.vjhemonc.com/video/l5dytu_15hs-al-amyloidosis-special-session-highlights-therapeutic-advances-and-ongoing-trials-in-the-field/ Dr Sanchorawala discussing highlights in therapeutic advances in AL amyloidosis at the International Myeloma society meeting in Athens, Greece in September 2023
Alexis Doria Receives Department of Medicine STAR Employee Recognition Award!
Congratulations to Alexis Doria, administrative manager of the Amyloidosis Center for receiving a Department of Medicine STAR Employee Recognition Award! The “STARDoM” program, sponsored by the Boston University Department of Medicine, seeks to recognize outstanding non-physician employees who work in all areas, including administration, clinical care and research.
Dr. Frederick Ruberg Promoted to Professor of Medicine at Boston University
Frederick Ruberg, MD, Medicine/Cardiovascular Medicine and Radiology, is associate chief for cardiovascular medicine at Boston Medical Center (BMC) and a clinical scientist with expertise in cardiac amyloidosis with continuous funding since 2005. He senior authored a number of important consensus guidelines statements relative to cardiac imaging, cardiac amyloidosis management and cardiac amyloidosis imaging/diagnosis. He currently […]
Lisa Mendelson, ANP Selected for BMC Medical-Dental Staff Clinician Council
Lisa Mendelson, ANP has been selected for the BMC Medical-Dental Staff Clinician Council for the period of 2023-2025. This is a richly deserved position for Lisa and we are so grateful for everything she does for the Amyloidosis Center and BMC as a whole. Way to go Lisa!